(firstQuint)The PARTNER 3 - AVIV Trial.

 A prospective, single-arm, multicenter clinical trial.

 The trial will enroll patients with a failing surgical or transcatheter bioprosthetic valve in the aortic position demonstrating stenosis and/or insufficiency.

.

 The PARTNER 3 - AVIV Trial@highlight

To assess the safety and effectiveness of the SAPIEN 3 (Edwards Lifesciences, Irvine, California) transcatheter heart valve in patients with a failing aortic bioprosthetic valve.

